Bacteremic pneumonia caused by extensively drug-resistant Streptococcus pneumoniae

Journal of Clinical Microbiology

Volumn 50, Issue 12, 2012, Pages 4175-4177

  Kang, Cheol In ^a   Baek, Jin Yang ^b   Jeon, Kyeongman ^a   Kim, So Hyun ^b   Chung, Doo Ryeon ^a   Peck, Kyong Ran ^a   Lee, Nam Yong ^a   Songa, Jae Hoon ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Asia Pacific Foundation for Infection Diseases (APFID)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFTOBIPROLE; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DORIPENEM; ERYTHROMYCIN; GATIFLOXACIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; MOXIFLOXACIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN;

AGED; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL PNEUMONIA; BACTERIUM DETECTION; BACTERIUM ISOLATE; CASE REPORT; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; DISEASE DURATION; FEVER; HEALTH CARE ASSOCIATED PNEUMONIA; HEMOPERITONEUM; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RESPIRATORY FAILURE; STREPTOCOCCUS PNEUMONIAE; TREATMENT DURATION; TREATMENT RESPONSE; VENTILATOR ASSOCIATED PNEUMONIA;

AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PENICILLIN-BINDING PROTEINS; PNEUMONIA, PNEUMOCOCCAL; SEQUENCE ANALYSIS, DNA; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS PNEUMONIAE;

EID: 84869224736     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01642-12     Document Type: Article

References (18)

1. Baek JY, Ko KS, Kang CI, Song JH, Peck KR. 2011. In vitro antibacterial activities of doripenem, imipenem, and meropenem against recent Streptococcus pneumoniae isolates. Diagn. Microbiol. Infect. Dis. 71:297-300.
2. CLSI. 2011. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. CLSI document M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Davidson R, et al. 2002. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N. Engl. J. Med. 346:747-750. (Pubitemid 34983995)
4. Enright MC, Spratt BG. 1998. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144(Pt 11):3049-3060. (Pubitemid 28515583)
5. Fogarty C, Goldschmidt R, Bush K. 2000. Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin. Clin. Infect. Dis. 31:613-615. (Pubitemid 32289603)
6. Ho PL, et al. 1999. Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong. Antimicrob. Agents Chemother. 43:1310-1313.
7. Ho PL, et al. 2001. Risk factors for acquisition of levofloxacin- resistant Streptococcus pneumoniae: a case-control study. Clin. Infect. Dis. 32:701-707. (Pubitemid 32221927)
8. Hsieh YC, et al. 2010. Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan. Clin. Microbiol. Infect. 16:973-978.
9. Jiménez MR, Bellido JL, Garcia Rodriguez JA. 2005. Risk factors associated with colonization by pneumococci with reduced susceptibility to fluoroquinolones in adult outpatients. J. Clin. Microbiol. 43:1193-1197. (Pubitemid 40364937)
10. Ko KS, Song JH. 2004. Evolution of erythromycin-resistant Streptococcus pneumoniae from Asian countries that contains erm(B) and mef(A) genes. J. Infect. Dis. 190:739-747.
11. Magiorakos AP, et al. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18:268-281.
12. Oh WS, et al. 2004. Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study. Microb. Drug Resist. 10:37-42. (Pubitemid 38529715)
13. Rossolini GM, et al. 2011. Comparative activity of ceftobiprole against Gram-positive and Gram-negative isolates from Europe and the Middle East: the CLASS study. J. Antimicrob. Chemother. 66:151-159.
14. Schrag SJ, et al. 2004. Emergence of Streptococcus pneumoniae with very-high-level resistance to penicillin. Antimicrob. Agents Chemother. 48:3016-3023. (Pubitemid 38989169)
15. Shouval DS, et al. 2010. Bacteremia caused by a highly-resistant Streptococcus pneumoniae serotype 19A circulating in a daycare center. Int. J. Infect. Dis. 14(Suppl. 3):e253-e255.
16. Song JH, et al. 2009. Changes of serotype and genotype in Streptococcus pneumoniae isolates from a Korean hospital in 2007. Diagn. Microbiol. Infect. Dis. 63:271-278.
17. Van Kerkhoven D, Peetermans WE, Verbist L, Verhaegen J. 2003. Breakthrough pneumococcal bacteraemia in patients treated with clarithromycin or oral beta-lactams. J. Antimicrob. Chemother. 51:691-696. (Pubitemid 36336164)
18. von Gottberg A, et al. 2008. Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study. Lancet 371:1108-1113.